PATENT CLAIM ANALYSIS

Application Number: 15770869
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "209100"]

Abstract:
Provided are a composition and a food or drink, having the effect of enhancing an immune response to an antigen, which is administered by another route such as subcutaneous injection, by orally administering to a subject, lactic acid bacteria, a culture thereof, a treated product thereof, or a composition comprising the same. An oral ingestion composition, which comprises a lactic acid bacterium strain that is  Lactococcus lactis  subsp.  lactis  enhancing the proliferation of cytotoxic T lymphocytes (CTL) and the generation of antibodies, or a culture or treated product thereof, and is used in combination with an antigen as a vaccine, wherein the oral ingestion composition is for use in enhancing the proliferation of cytotoxic T lymphocytes (CTL) specific to the antigen and the generation of antibodies specific to the antigen.

Claim (Index 10):
A kit for enhancing the proliferation of antigen-specific cytotoxic T lymphocytes (CTL) and the generation of antigen-specific antibodies, wherein the kit comprises the oral ingestion composition according to  claim 1 , and the antigen.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 2.11429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09171916', '09875264', '11942598', '11942620', '14138421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7364344236777967
- 35 USC 102 Novelty (BERT): 0.4951730618530544
- Combined Prediction Score: 0.7123082874953225
- Mean Citation Score: 213.739966
- Max Citation Score: 218.01486
- Similarity Product: 152.2470676369822

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test